Acacia-fiber-constipation-randomized-trial: What the Evidence Says

Acacia-fiber-constipation-randomized-trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass

3 min read · 485 wordsReviewed August 2026
Stunning close-up of Albizia flower showcasing delicate filaments and lush green foliage. - Evidence evidence guide for acacia-fiber-constipation-randomized-trial
Photo by Jeffry Surianto on Pexels · Pexels License

Quick Answer

Acacia fiber constipation randomized trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 randomized trial.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Acacia-fiber-constipation-randomized-trial: What the Evidence Says

Quick Answer

Acacia-fiber-constipation-randomized-trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 randomized trial.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Correction to: Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial randomized trial 2 2025-03-22 10.1007/s00394-025-03586-0

What The Sources Report

  • Linear mixed model analysis showed that Acacia fiber and Probiotic Bla80 significantly increased stool frequency compared to placebo (&#8201;<&#8201;0.001 and&#8201;=&#8201;0.02) for Acacia fiber and Probiotic Bla80, respectively and should have appeared as shown below A B n n n P P Daily variation in stool frequency and change in stool frequency per week. [JanssenDuijghuijsen Lonneke (2025); evidence level 2]
  • Linear mixed model analysis showed that Acacia fiber and Probiotic Bla80 significantly increased stool frequency compared to placebo (&#8201;<&#8201;0.001 and&#8201;=&#8201;0.02) for Acacia fiber and Probiotic Bla80, respectively Several figure subtitles have mistakenly been embedded within the text paragraphs instead of being placed in the caption of Figs.&#160;2, 3, 4 and 5. [JanssenDuijghuijsen Lonneke (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For acacia-fiber-constipation-randomized-trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • JanssenDuijghuijsen Lonneke (2025). Correction to: Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial. DOI: 10.1007/s00394-025-03586-0. PMCID: PMC11929710. PMID: 40119929. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11929710/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 15, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →